Biological dosimetry by the triage dicentric chromosome assay: Potential implications for treatment of acute radiation syndrome in radiological mass casualties

Horst Romm, Ruth C. Wilkins, C. Norman Coleman, Patricia K. Lillis-Hearne, Terry C. Pellmar, Gordon K. Livingston, Akio A. Awa, Mark S. Jenkins, Mitsuaki A. Yoshida, Ursula Oestreicher, Pataje G S Prasanna

Research output: Contribution to journalArticle

Abstract

Biological dosimetry is an essential tool for estimating radiation dose. The dicentric chromosome assay (DCA) is currently the tool of choice. Because the assay is labor-intensive and time-consuming, strategies are needed to increase throughput for use in radiation mass casualty incidents. One such strategy is to truncate metaphase spread analysis for triage dose estimates by scoring 50 or fewer metaphases, compared to a routine analysis of 500 to 1000 metaphases, and to increase throughput using a large group of scorers in a biodosimetry network. Previously, the National Institutes for Allergies and Infectious Diseases (NIAID) and the Armed Forces Radiobiology Research Institute (AFRRI) sponsored a double-blinded interlaboratory comparison among five established international cytogenetic biodosimetry laboratories to determine the variability in calibration curves and in dose measurements in unknown, irradiated samples. In the present study, we further analyzed the published data from this previous study to investigate how the number of metaphase spreads influences dose prediction accuracy and how this information could be of value in the triage and management of people at risk for the acute radiation syndrome (ARS). Although, as expected, accuracy decreased with lower numbers of metaphase spreads analyzed, predicted doses by the laboratories were in good agreement and were judged to be adequate to guide diagnosis and treatment of ARS. These results demonstrate that for rapid triage, a network of cytogenetic biodosimetry laboratories can accurately assess doses even with a lower number of scored metaphases.

Original languageEnglish (US)
Pages (from-to)397-404
Number of pages8
JournalRadiation Research
Volume175
Issue number3
DOIs
StatePublished - Mar 2011
Externally publishedYes

Fingerprint

Acute Radiation Syndrome
Mass Casualty Incidents
casualties
Triage
chromosomes
Metaphase
dosimeters
Chromosomes
dosage
radiation
Cytogenetics
armed forces
National Institute of Allergy and Infectious Diseases (U.S.)
Radiation
Radiobiology
radiobiology
scoring
labor
infectious diseases
Calibration

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Biophysics
  • Radiation

Cite this

Romm, H., Wilkins, R. C., Coleman, C. N., Lillis-Hearne, P. K., Pellmar, T. C., Livingston, G. K., ... Prasanna, P. G. S. (2011). Biological dosimetry by the triage dicentric chromosome assay: Potential implications for treatment of acute radiation syndrome in radiological mass casualties. Radiation Research, 175(3), 397-404. https://doi.org/10.1667/RR2321.1

Biological dosimetry by the triage dicentric chromosome assay : Potential implications for treatment of acute radiation syndrome in radiological mass casualties. / Romm, Horst; Wilkins, Ruth C.; Coleman, C. Norman; Lillis-Hearne, Patricia K.; Pellmar, Terry C.; Livingston, Gordon K.; Awa, Akio A.; Jenkins, Mark S.; Yoshida, Mitsuaki A.; Oestreicher, Ursula; Prasanna, Pataje G S.

In: Radiation Research, Vol. 175, No. 3, 03.2011, p. 397-404.

Research output: Contribution to journalArticle

Romm, H, Wilkins, RC, Coleman, CN, Lillis-Hearne, PK, Pellmar, TC, Livingston, GK, Awa, AA, Jenkins, MS, Yoshida, MA, Oestreicher, U & Prasanna, PGS 2011, 'Biological dosimetry by the triage dicentric chromosome assay: Potential implications for treatment of acute radiation syndrome in radiological mass casualties', Radiation Research, vol. 175, no. 3, pp. 397-404. https://doi.org/10.1667/RR2321.1
Romm, Horst ; Wilkins, Ruth C. ; Coleman, C. Norman ; Lillis-Hearne, Patricia K. ; Pellmar, Terry C. ; Livingston, Gordon K. ; Awa, Akio A. ; Jenkins, Mark S. ; Yoshida, Mitsuaki A. ; Oestreicher, Ursula ; Prasanna, Pataje G S. / Biological dosimetry by the triage dicentric chromosome assay : Potential implications for treatment of acute radiation syndrome in radiological mass casualties. In: Radiation Research. 2011 ; Vol. 175, No. 3. pp. 397-404.
@article{84e2d06127364fe4bb2c2def38aa6841,
title = "Biological dosimetry by the triage dicentric chromosome assay: Potential implications for treatment of acute radiation syndrome in radiological mass casualties",
abstract = "Biological dosimetry is an essential tool for estimating radiation dose. The dicentric chromosome assay (DCA) is currently the tool of choice. Because the assay is labor-intensive and time-consuming, strategies are needed to increase throughput for use in radiation mass casualty incidents. One such strategy is to truncate metaphase spread analysis for triage dose estimates by scoring 50 or fewer metaphases, compared to a routine analysis of 500 to 1000 metaphases, and to increase throughput using a large group of scorers in a biodosimetry network. Previously, the National Institutes for Allergies and Infectious Diseases (NIAID) and the Armed Forces Radiobiology Research Institute (AFRRI) sponsored a double-blinded interlaboratory comparison among five established international cytogenetic biodosimetry laboratories to determine the variability in calibration curves and in dose measurements in unknown, irradiated samples. In the present study, we further analyzed the published data from this previous study to investigate how the number of metaphase spreads influences dose prediction accuracy and how this information could be of value in the triage and management of people at risk for the acute radiation syndrome (ARS). Although, as expected, accuracy decreased with lower numbers of metaphase spreads analyzed, predicted doses by the laboratories were in good agreement and were judged to be adequate to guide diagnosis and treatment of ARS. These results demonstrate that for rapid triage, a network of cytogenetic biodosimetry laboratories can accurately assess doses even with a lower number of scored metaphases.",
author = "Horst Romm and Wilkins, {Ruth C.} and Coleman, {C. Norman} and Lillis-Hearne, {Patricia K.} and Pellmar, {Terry C.} and Livingston, {Gordon K.} and Awa, {Akio A.} and Jenkins, {Mark S.} and Yoshida, {Mitsuaki A.} and Ursula Oestreicher and Prasanna, {Pataje G S}",
year = "2011",
month = "3",
doi = "10.1667/RR2321.1",
language = "English (US)",
volume = "175",
pages = "397--404",
journal = "Radiation Research",
issn = "0033-7587",
publisher = "Radiation Research Society",
number = "3",

}

TY - JOUR

T1 - Biological dosimetry by the triage dicentric chromosome assay

T2 - Potential implications for treatment of acute radiation syndrome in radiological mass casualties

AU - Romm, Horst

AU - Wilkins, Ruth C.

AU - Coleman, C. Norman

AU - Lillis-Hearne, Patricia K.

AU - Pellmar, Terry C.

AU - Livingston, Gordon K.

AU - Awa, Akio A.

AU - Jenkins, Mark S.

AU - Yoshida, Mitsuaki A.

AU - Oestreicher, Ursula

AU - Prasanna, Pataje G S

PY - 2011/3

Y1 - 2011/3

N2 - Biological dosimetry is an essential tool for estimating radiation dose. The dicentric chromosome assay (DCA) is currently the tool of choice. Because the assay is labor-intensive and time-consuming, strategies are needed to increase throughput for use in radiation mass casualty incidents. One such strategy is to truncate metaphase spread analysis for triage dose estimates by scoring 50 or fewer metaphases, compared to a routine analysis of 500 to 1000 metaphases, and to increase throughput using a large group of scorers in a biodosimetry network. Previously, the National Institutes for Allergies and Infectious Diseases (NIAID) and the Armed Forces Radiobiology Research Institute (AFRRI) sponsored a double-blinded interlaboratory comparison among five established international cytogenetic biodosimetry laboratories to determine the variability in calibration curves and in dose measurements in unknown, irradiated samples. In the present study, we further analyzed the published data from this previous study to investigate how the number of metaphase spreads influences dose prediction accuracy and how this information could be of value in the triage and management of people at risk for the acute radiation syndrome (ARS). Although, as expected, accuracy decreased with lower numbers of metaphase spreads analyzed, predicted doses by the laboratories were in good agreement and were judged to be adequate to guide diagnosis and treatment of ARS. These results demonstrate that for rapid triage, a network of cytogenetic biodosimetry laboratories can accurately assess doses even with a lower number of scored metaphases.

AB - Biological dosimetry is an essential tool for estimating radiation dose. The dicentric chromosome assay (DCA) is currently the tool of choice. Because the assay is labor-intensive and time-consuming, strategies are needed to increase throughput for use in radiation mass casualty incidents. One such strategy is to truncate metaphase spread analysis for triage dose estimates by scoring 50 or fewer metaphases, compared to a routine analysis of 500 to 1000 metaphases, and to increase throughput using a large group of scorers in a biodosimetry network. Previously, the National Institutes for Allergies and Infectious Diseases (NIAID) and the Armed Forces Radiobiology Research Institute (AFRRI) sponsored a double-blinded interlaboratory comparison among five established international cytogenetic biodosimetry laboratories to determine the variability in calibration curves and in dose measurements in unknown, irradiated samples. In the present study, we further analyzed the published data from this previous study to investigate how the number of metaphase spreads influences dose prediction accuracy and how this information could be of value in the triage and management of people at risk for the acute radiation syndrome (ARS). Although, as expected, accuracy decreased with lower numbers of metaphase spreads analyzed, predicted doses by the laboratories were in good agreement and were judged to be adequate to guide diagnosis and treatment of ARS. These results demonstrate that for rapid triage, a network of cytogenetic biodosimetry laboratories can accurately assess doses even with a lower number of scored metaphases.

UR - http://www.scopus.com/inward/record.url?scp=79952124583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952124583&partnerID=8YFLogxK

U2 - 10.1667/RR2321.1

DO - 10.1667/RR2321.1

M3 - Article

C2 - 21388284

AN - SCOPUS:79952124583

VL - 175

SP - 397

EP - 404

JO - Radiation Research

JF - Radiation Research

SN - 0033-7587

IS - 3

ER -